Literature DB >> 15271581

Depression: a case of neuronal life and death?

Ronald S Duman1.   

Abstract

Preclinical and clinical studies have demonstrated that stress or depression can lead to atrophy and cell loss in limbic brain structures that are critically involved in depression, including the hippocampus. Studies in experimental animals demonstrate that decreased birth of new neurons in adult hippocampus could contribute to this atrophy. In contrast, antidepressant treatment increases neurogenesis in the hippocampus of adult animals and blocks the effects of stress. Moreover, blockade of hippocampal neurogenesis blocks the actions of antidepressants in behavioral models of depression, demonstrating a direct link between behavior and new cell birth. This perspective reviews the literature in support of the hypothesis that altered birth of new neurons in the adult brain contributes to the etiology and treatment of depression and considers research strategies to test this hypothesis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15271581     DOI: 10.1016/j.biopsych.2004.02.033

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  148 in total

1.  Ozone modulates the effects of imipramine on immobility in the forced swim test, and nonspecific parameters of hippocampal oxidative stress in the rat.

Authors:  Mmalebuso L Mokoena; Brian H Harvey; Douglas W Oliver; Christiaan B Brink
Journal:  Metab Brain Dis       Date:  2010-05-09       Impact factor: 3.584

2.  Blockade of astrocytic glutamate uptake in rats induces signs of anhedonia and impaired spatial memory.

Authors:  Anita J Bechtholt-Gompf; Hali V Walther; Martha A Adams; William A Carlezon; Dost Ongür; Bruce M Cohen
Journal:  Neuropsychopharmacology       Date:  2010-06-09       Impact factor: 7.853

3.  The GABAergic deficit hypothesis of major depressive disorder.

Authors:  B Luscher; Q Shen; N Sahir
Journal:  Mol Psychiatry       Date:  2010-11-16       Impact factor: 15.992

Review 4.  Stress, depression and Parkinson's disease.

Authors:  Ann M Hemmerle; James P Herman; Kim B Seroogy
Journal:  Exp Neurol       Date:  2011-10-06       Impact factor: 5.330

Review 5.  New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates--Nrf2 activators and GSK-3 inhibitors.

Authors:  Michael Maes; Zdenĕk Fišar; Miguel Medina; Giovanni Scapagnini; Gabriel Nowak; Michael Berk
Journal:  Inflammopharmacology       Date:  2012-01-24       Impact factor: 4.473

Review 6.  Adult neurogenesis, cell cycle and drug discovery in psychiatry.

Authors:  Robert N Pechnick; Vera Chesnokova
Journal:  Neuropsychopharmacology       Date:  2009-01       Impact factor: 7.853

Review 7.  Electrical stimulation of cranial nerves in cognition and disease.

Authors:  Devin Adair; Dennis Truong; Zeinab Esmaeilpour; Nigel Gebodh; Helen Borges; Libby Ho; J Douglas Bremner; Bashar W Badran; Vitaly Napadow; Vincent P Clark; Marom Bikson
Journal:  Brain Stimul       Date:  2020-02-23       Impact factor: 8.955

8.  Adult neurogenesis is functionally associated with AD-like neurodegeneration.

Authors:  Qian Chen; Akira Nakajima; Se Hoon Choi; Xiaoli Xiong; Sangram S Sisodia; Ya-Ping Tang
Journal:  Neurobiol Dis       Date:  2007-11-05       Impact factor: 5.996

Review 9.  Neuroimaging in posttraumatic stress disorder and other stress-related disorders.

Authors:  J Douglas Bremner
Journal:  Neuroimaging Clin N Am       Date:  2007-11       Impact factor: 2.264

10.  Eszopiclone and fluoxetine enhance the survival of newborn neurons in the adult rat hippocampus.

Authors:  Xiaowei W Su; Xiao-Yuan Li; Mounira Banasr; Ronald S Duman
Journal:  Int J Neuropsychopharmacol       Date:  2009-09-24       Impact factor: 5.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.